#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Partial lipodystrophy Transplant rejection ROHHAD syndrome Familial haemophagocytic lymphohistiocytosis Keratosis follicular Hereditary hypophosphataemic rickets Angelman's syndrome Systemic candida Aplastic anaemia Narcolepsy Metachromatic leukodystrophy Breast angiosarcoma metastatic Malignant central nervous system neoplasm Penile cancer Oesophageal squamous cell carcinoma stage II More trials…

Learn about Rare Diseases

Alexander disease – Diagnostics Angiosarcoma recurrent – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Congenital nephrogenic diabetes insipidus – Treatment Netherton’s syndrome – Treatment Burkitt’s lymphoma – Basic Information Hairy cell leukaemia – Diagnostics Splenic marginal zone lymphoma – Treatment Congenital nephrogenic diabetes insipidus Congenital nephrogenic diabetes insipidus – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Seladelpar Ponsegromab Wt1/Il15/Il15Ra Mrna Dc Lutetium (177Lu) Edotreotide Desflurane Mezigdomide Isaralgagene Civaparvovec GOVORESTAT Adrenaline Acid Tartrate Bp Volixibat Namilumab Citalopram Hydrochloride Inotuzumab Ozogamicin Naloxone Sodium Iodide (123 I) OMTX705 Dalteparin Sodium Prednisolone Acetate Amy109 Zanubrutinib More therapies…

Learn about Your Condition

Mesothelioma Peritoneal neoplasm Pneumococcal infection Mantle cell lymphoma recurrent Peptostreptococcus infection Altered state of consciousness Hypereosinophilic syndrome HER2 positive gastric cancer Procedural anxiety Hypertension Cardiac valve disease Diabetes insipidus Anal fissure Mesothelioma malignant Pemphigus More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Acute kidney injury

Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

Not recruiting

2 1 1 1
Investigated Diseases:
- Hepatorenal syndrome
- Acute kidney injury
Investigated Drugs:
- R2R01
- Terlipressin Acetate
Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Acute kidney injury
Investigated Drugs:
- Ravulizumab
+2
Study on the Effects of Irbesartan After Acute Kidney Injury in Patients Discharged from ICU

Not recruiting

3 1 1
Investigated Drugs:
- Irbesartan

1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Acute kidney injury

Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Study on the Effects of Irbesartan After Acute Kidney Injury in Patients Discharged from ICU

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies